Biosensor approaches for the detection of autoantibodies in human serum

A microfluidic, dual-purpose sensor for in vitro detection of Enterobacteriaceae and biotinylated antibodies

In this paper, we present a versatile, dual-purpose sensor for in vitro detection of Enterobacteriaceae (e.g. Escherichia coli) and biotinylated antibodies (e.g. IgG rabbit polyclonal antibodies), based on different detection principles for each bioanalyte. These bioanalytes are tagged individually with functionalized magnetic microparticles, suspended into a static fluid and injected into a microfluidic channel. Without the need for bulk or complicated pumping systems, the functionalized microparticles are set in motion by a magnetic force exerted on them by integrated microconductors. The fundamental detection principle is the decrease in the velocity of the microparticles that are loaded with the respective bioanalyte, due to factors inhibiting their motion. The velocity of the unloaded, bare microparticles is used as a reference. We discovered a novel mechanism on which the constrained particle motion is based; in the case of E. coli, the inhibiting factor is the enhanced Stokes' drag force due to the greater volume and altered hydrodynamic shape, whereas in the case of biotinylated antibodies, it is the increased friction force at the interface between the modified microparticle and the biosensor's surface. Friction force is for the first time employed in a scheme for resolving biomolecules. Integrated magnetic microsensors are used for the velocity measurements by detecting the microparticles' stray field. Moreover, we developed a biocompatible, easy to implement and reliable surface modification that practically diminishes the problem of bioadhesion on the sensor's surface.

Surface plasmon resonance applications in clinical analysis

In the last 20 years, surface plasmon resonance (SPR) and its advancement with imaging (SPRi) emerged as a suitable and reliable platform in clinical analysis for label-free, sensitive, and real-time monitoring of biomolecular interactions. Thus, we report in this review the state of the art of clinical target detection with SPR-based biosensors in complex matrices (e.g., serum, saliva, blood, and urine) as well as in standard solution when innovative approaches or advanced instrumentations were employed for improved detection. The principles of SPR-based biosensors are summarized first, focusing on the physical properties of the transducer, on the assays design, on the immobilization chemistry, and on new trends for implementing system analytical performances (e.g., coupling with nanoparticles (NPs). Then we critically review the detection of analytes of interest in molecular diagnostics, such as hormones (relevant also for anti-doping control) and biomarkers of interest in inflammatory, cancer, and heart failure diseases. Antibody detection is reported in relation to immune disorder diagnostics. Subsequently, nucleic acid targets are considered for revealing genetic diseases (e.g., point mutation and single nucleotides polymorphism, SNPs) as well as new emerging clinical markers (microRNA) and for pathogen detection. Finally, examples of pathogen detection by immunosensing were also analyzed. A parallel comparison with the reference methods was duly made, indicating the progress brought about by SPR technologies in clinical routine analysis.